Literature DB >> 5917334

Aerogenic immunization of man with live Tularemia vaccine.

R B Hornick, H T Eigelsbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5917334      PMCID： PMC378235          DOI： 10.1128/br.30.3.532-538.1966

Source DB:  PubMed          Journal:  Bacteriol Rev        ISSN： 0005-3678


× No keyword cloud information.
  16 in total

1.  SIMULTANEOUS AEROSOL IMMUNIZATION OF MONKEYS WITH LIVE TULAREMIA AND LIVE VENEZUELAN EQUINE ENCEPHALOMYELITIS VACCINES.

Authors:  W D SAWYER; R W KUEHNE; W S GOCHENOUR
Journal:  Mil Med       Date:  1964-11       Impact factor: 1.437

2.  Armed Forces Epidemiological Board activities of the Commission on Epidemiological Survey, 1961.

Authors:  D CROZIER; T E WOODWARD
Journal:  Mil Med       Date:  1962-09       Impact factor: 1.437

3.  Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine.

Authors:  H T EIGELSBACH; J J TULIS; E L OVERHOLT; W R GRIFFITH
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

4.  Tularemia vaccine study. II. Respiratory challenge.

Authors:  S SASLAW; H T EIGELSBACH; J A PRIOR; H E WILSON; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

5.  Airborne immunization against tuberculosis.

Authors:  M L COHN; C L DAVIS; G MIDDLEBROOK
Journal:  Science       Date:  1958-11-21       Impact factor: 47.728

6.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

Authors:  F R McCrumb
Journal:  Bacteriol Rev       Date:  1961-09

7.  LIVE TULAREMIA VACCINE I. : Host-Parasite Relationship in Monkeys Vaccinated Intracutaneously or Aerogenically.

Authors:  H T Eigelsbach; J J Tulis; M H McGavran; J D White
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

8.  Distemper Immunization of Ferrets by Nebulization with Egg Adapted Virus.

Authors:  J R Gorham; R W Leader; J C Gutierrez
Journal:  Science       Date:  1954-01-22       Impact factor: 47.728

9.  Studies on the variation of Bacterium tularense.

Authors:  H T EIGELSBACH; W BRAUN; R D HERRING
Journal:  J Bacteriol       Date:  1951-05       Impact factor: 3.490

10.  Morphologic and Immunohistochemical Studies of the Pathogenesis of Infection and Antibody Formation Subsequent to Vaccination of Macaca irus With an Attenuated Strain of Pasteurella tularensis: II. Aerogenic Vaccination.

Authors:  J D White; M H McGavran; P A Prickett; J J Tulis; H T Eigelsbach
Journal:  Am J Pathol       Date:  1962-10       Impact factor: 4.307
View more
  88 in total

1.  A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.

Authors:  Qingmei Jia; Bai-Yu Lee; Richard Bowen; Barbara Jane Dillon; Susan M Som; Marcus A Horwitz
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Authors:  Leah E Cole; Michelle H W Laird; Anna Seekatz; Araceli Santiago; Zhaozhao Jiang; Eileen Barry; Kari Ann Shirey; Katherine A Fitzgerald; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

3.  Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

Authors:  H M El Sahly; R L Atmar; S M Patel; J M Wells; T Cate; M Ho; K Guo; M F Pasetti; D E Lewis; M B Sztein; W A Keitel
Journal:  Vaccine       Date:  2009-06-28       Impact factor: 3.641

4.  A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Authors:  Susan Twine; Mona Byström; Wangxue Chen; Mats Forsman; Igor Golovliov; Anders Johansson; John Kelly; Helena Lindgren; Kerstin Svensson; Carl Zingmark; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Authors:  Leah E Cole; Barbara J Mann; Kari Ann Shirey; Katharina Richard; Yang Yang; Patricia J Gearhart; Kirsty L Chesko; Rose M Viscardi; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2011-07-12       Impact factor: 4.962

6.  T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.

Authors:  Carmen M Collazo; Anda I Meierovics; Roberto De Pascalis; Terry H Wu; C Rick Lyons; Karen L Elkins
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

7.  Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Authors:  J Wayne Conlan; Hua Shen; Igor Golovliov; Carl Zingmark; Petra C F Oyston; Wangxue Chen; Robert V House; Anders Sjöstedt
Journal:  Vaccine       Date:  2009-12-16       Impact factor: 3.641

8.  Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Authors:  Jieh-Juen Yu; Tatareddy Goluguri; M Neal Guentzel; James P Chambers; Ashlesh K Murthy; Karl E Klose; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

Review 9.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

10.  Identification of an essential Francisella tularensis subsp. tularensis virulence factor.

Authors:  Aiping Qin; David W Scott; Jennifer A Thompson; Barbara J Mann
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.